FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2020/03/024089 [Registered on: 19/03/2020] Trial Registered Prospectively
Last Modified On: 19/03/2020
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   Management of Psoriasis with Kushtanashana rasa and Kutaja suryapaki taila -A clinical study  
Scientific Title of Study   A Randomised controlled parallel group clinical study to evaluate Kushtanashana rasa and panchatiktha ghritha guggulu with Kutaja patra suryapaki taila external application in the management of Eka Kushta w.s.r to Psoriasis  
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Supreetha M  
Designation  PG Scholar  
Affiliation  Sri Sri College of Ayurvedic Science and Research 
Address  Room no- 304, Department of Kayachikitsa 21st KM, Kanakapura Road, Udayapura PO

Bangalore
KARNATAKA
560082
India 
Phone  8660550443  
Fax    
Email  supree99@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Neelakanta J Sajjanar 
Designation  Assosciate proffessor 
Affiliation  Sri Sri College of Ayurvedic Science and Research 
Address  Room no- 304, Department of Kayachikitsa 21st KM, Kanakapura Road, Udayapura PO

Bangalore
KARNATAKA
560082
India 
Phone  9844812331  
Fax    
Email  neelkant.ayu@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Supreetha M  
Designation  PG Scholar  
Affiliation  Sri Sri College of Ayurvedic Science and Research 
Address  Room no- 304, Department of Kayachikitsa 21st KM, Kanakapura Road, Udayapura PO

Bangalore
KARNATAKA
560082
India 
Phone  8660550443  
Fax    
Email  supree99@gmail.com  
 
Source of Monetary or Material Support  
Room no- 05, Department of Kayachikitsa Sri Sri College of Ayurvedic Science and Rsearch Hospital 21st KM, Kanakapura Road, Udayapura PO 
 
Primary Sponsor  
Name  Dr Supreetha M 
Address  PG Scholar Department of Kayachikitsa 21st KM Kanakapura Main road,Udayapura Post,Bangalore 
Type of Sponsor  Other [Self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr SupreethaM  Sri Sri College of Ayurvedic Science and Research Hospital   Room no- 05, Department of Kayachikitsa Sri Sri College of Ayurvedic Science and Rsearch Hospital 21st KM, Kanakapura Road, Udayapura PO
Bangalore
KARNATAKA 
8660550443

supree99@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Sri Sri Institutional Ethical Committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: L409||Psoriasis, unspecified,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Kushtanashana Rasa  Kushtanashana Rasa is a formulation containing churnas of Shireesha,haritaki,vibhitaki,chirabilwa,Kakodumbara, shudha tankana in equal quantity mixed in quantity sufficient of Gomutra, followed by 12gms of draksha. Dosage: 12gm of churna, orally once daily for 49 days  
Comparator Agent  Panchatiktha ghritha guggulu and Kutaja Suryapaki Taila   1.Panchatiktha Ghritha Guggulu is a tablet having Main ingredients :Nimba , Kantakari, Patola ,Guduchi, Vasa ,Shuddha guggulu,other ingredients :Patha, vidanga, bhallataka, suradaru, gajopakulya, yavakshra, sarjakshara, nagara, mishreya , kushta, tejovati, maricha vatsaka, deepyaka, agni, rohini, vacha ,kanamoola, yuktha, manjishta, ativisha, vishani and Water for decoction along with Ghritha. Dosage:4 tablets, orally twice daily, after food for 49 days. 2.Kutaja Suryapaki taila is a taila having ingredients Kutaja and tila taila.Applied externally on lesions twice daily.  
 
Inclusion Criteria  
Age From  21.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  1.With classical signs and symptoms of Eka Kushta.
2. Presenting with signs and symptoms of Psoriasis.
3. The Subjects willing to give informed consent for research.
 
 
ExclusionCriteria 
Details  1.Subjects aged <21 years and > 60 years of age .

2.Subjects suffering from complications of Psoriasis like Psoriatic arthritis .

3.Subjects suffering from Non–psoriatic conditions of skin, IHD, Immune compromised patients and other uncontrolled systemic diseases.

4.Disease which interferes with the course of disease and treatment.

5.Pregnant and Lactating women.
 
 
Method of Generating Random Sequence   Coin toss, Lottery, toss of dice, shuffling cards etc 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
Reduction in PASI Scale score  16th day,32nd day,49th day and 65th day  
 
Secondary Outcome  
Outcome  TimePoints 
Reduction in DLQI scale score  16th day,32nd day,49th day and 65th day 
 
Target Sample Size   Total Sample Size="30"
Sample Size from India="30" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   23/03/2020 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   NIL 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Brief Summary   Psoriasis is one of the most common skin disease which has no permanent cure available.The current treatment modalities available are palliative lotions,ointments and PUVA (Psoralin Ultra Violet A) and Biologic injections which are very expensive and is recommended for long period of time. Psoriasis is having high recurrance rate and often the patient with Psoriasis experience diminished quality of life. Hence there is a need to contribute with safe and effective remedy for its treatment.
Hypothesis:
Null Hypothesis-H0 :The efficacy of Kushtanashana Rasa in the mangement of Eka kushta w.s.r to Psoriasis is insignificant.
Research Hypothesis- H1 :1. The efficacy of Kushtanashana Rasa in the management of Eka kushta w.s.r to Psoriasis is significant.
2. The efficacy of Kushtanashana Rasa in the management of Eka kushta w.s.r to Psoriasis is significant in comparison to control groups.
 
Close